Accuracy and Patient Acceptability of Flash Glucose Monitoring in Low Income Women with Diabetes in Pregnancy

Date Added
January 18th, 2022
PRO Number
Pro00117649
Researcher
Matthew Finneran

List of Studies


Keywords
Obstetrics and Gynecology
Summary

This study will access the accuracy of the FreeStyle Libre system when compared to a finger stick blood glucose test. We will also look at a patients satisfaction with the Freestyle Libre system.

Institution
MUSC
Recruitment Contact
Jesslyn Payne
843-792-7525
paynej@musc.edu

Alinity m HR HPV Specimen Collection Study from Women Referred to Colposcopy

Date Added
July 19th, 2021
PRO Number
Pro00109802
Researcher
Ashlyn Savage

List of Studies


Keywords
Obstetrics and Gynecology
Summary

The purpose of this study is to enroll women undergoing colposcopy per the standard of care to collect cervical liquid-based cytology (LBC) specimens as well as cervical biopsy specimens and to determine their cervical disease status, which is based on review of cervical biopsy specimens.

Institution
MUSC
Recruitment Contact
Jesslyn Payne
843-792-7525
paynej@musc.edu

The IMpact of the Roche Elecsys sFlt-1/PlGF ratio on clinical decision making in suspected PreEclampsia (TIME PE)

Date Added
July 1st, 2021
PRO Number
Pro00112134
Researcher
Eugene Chang

List of Studies


Keywords
Obstetrics and Gynecology
Summary

This study will evaluate clinical management and pregnancy outcomes of
pregnant women exhibiting signs and symptoms of preeclampsia. We will investigate if this test can accurately rule-out PE within one week and its impact on clinical decisions.

Institution
MUSC
Recruitment Contact
Jesslyn Payne
843-792-7525
paynej@musc.edu

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF SAGE-217 IN THE TREATMENT OF ADULTS WITH SEVERE POSTPARTUM DEPRESSION

Date Added
September 8th, 2020
PRO Number
Pro00101329
Researcher
Constance Guille

List of Studies


Keywords
Obstetrics and Gynecology, Post Partum Depression, Psychiatry
Summary

The main purpose of this study is to determine if treatment with SAGE-217 reduces depressive symptoms in adults with severe postpartum depression (PPD). SAGE-217 is is an investigational drug, which means that it is not yet approved to treat PPD. Participation in the study will last up to 76 days and includes a 14 day treatment period where SAGE-217 is taken by oral pill daily. Visits will take approximately 1 to 3 hours.

Institution
MUSC
Recruitment Contact
Natalie Naylon
843-792-5824
naylon@musc.edu

Umbilical Cord-derived Mesenchymal Stem Cells (MSC) for Cellular Therapy

Date Added
June 16th, 2020
PRO Number
Pro00099509
Researcher
Hongjun Wang

List of Studies